SPHINGOLIPIDS IN INTEGRIN-MEDIATED OLIGODENDROCYTE SURVIVAL SIGNALING IN HYPOXI
缺氧时整合素介导的少突胶质细胞生存信号转导中的鞘脂
基本信息
- 批准号:7381854
- 负责人:
- 金额:$ 12.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Oligodendrocytes are critical regulators of nervous system function and play a central role in many acute neurological disorders, including stroke. Glutamate excitotoxicity contributes to ischemic oligodendrocyte injury; however, it is not clear what the intracellular mechanisms are leading to cell death. This proposal examines a hypothesis that over-activation of glutamate receptors and hypoxia/ischemia reduces oligodendrocyte survival, leading to apoptosis, which is mediated in part by ceramide and prevented by sphingosine-1-phosphate. We use primary cultures of oligodendrocytes and a mouse model of stroke to study the role of sphingolipids in neural cells. We assess cellular activity using fluorescence measurements of cell survival, western blotting, immunoprecipitation and high performance lipid chromatography coupled with mass spectrometry. In cultured oligodendrocytes, we found that stimulation of glutamate receptor induced biphasic increase in endogenous ceramide levels via two different mechanisms. The data suggest that an early increase in C18-ceramide level, which is generated by de novo synthesis and it is not accompanied with sphingomyelin hydrolysis could play a role in protecting oligodendrocytes from glutamate-induced damage. Thus, in isolated mitochondria, we found that C18-ceramide is a powerful inhibitor of mitochondrial permeability transition pore which is a pivotal part of apoptotic machinery. This is the first demonstration that endogenous ceramide could block the pore. The late increase in ceramide levels was accompanied by a substantial sphingomyelin hydrolysis. The data provide further support for our hypothesis and suggest that the late increase in ceramide level could manifest a pro-apoptotic role of ceramide in oligodendrocyte injury. It also raises the question as to what ceramide-generating enzymes are activated by ischemic insult. In the animal model of stroke, brief cerebral ischemia increased ceramide levels in brain without apparent sphingomyelin hydrolysis. These data are in line with our findings in cultured oligodendrocytes and suggest that the early activation of de novo ceramide synthesis occurs in cerebral ischemic brain injury.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子弹和调查员(PI)可能已经从其他NIH来源获得了主要资金,因此可以在其他清晰的条目中代表。列出的机构适用于该中心,这不一定是调查员的机构。少突胶质细胞是神经系统功能的关键调节剂,并且在包括中风在内的许多急性神经系统疾病中起着核心作用。谷氨酸兴奋性有助于缺血性少突胶质细胞损伤。但是,尚不清楚细胞内机制导致细胞死亡。该提案研究了一个假设,即谷氨酸受体和缺氧/缺血的过度激活降低了少突胶质细胞的存活,导致凋亡,导致细胞凋亡,部分是由神经酰胺介导的,并由鞘氨碱1-磷酸盐预防。我们使用少突胶质细胞的原发性培养物和中风的小鼠模型来研究鞘脂在神经细胞中的作用。我们使用细胞存活,蛋白质印迹,免疫沉淀和高性能脂质色谱和质谱法的荧光测量评估细胞活性。在培养的少突胶质细胞中,我们发现通过两种不同的机制刺激谷氨酸受体诱导的内源性神经酰胺水平的双相增加。数据表明,通过从头合成产生的C18-钙酰胺水平的早期增加,并且不伴有鞘氨素水解,可以在保护少突胶质细胞免受谷氨酸诱导的损伤方面发挥作用。因此,在孤立的线粒体中,我们发现C18-钙酰胺是线粒体通透性过渡孔的强大抑制剂,这是凋亡机制的关键部分。这是内源性神经酰胺可以阻塞孔的第一次演示。神经酰胺水平的晚期增加伴随着大量的鞘磷脂水解。数据为我们的假设提供了进一步的支持,并表明神经酰胺水平的晚期增加可能表现出神经酰胺在少突胶质细胞损伤中的促凋亡作用。这也提出了一个问题,即通过缺血性侮辱激活哪种神经酰胺生成酶。在中风的动物模型中,短暂的脑缺血增加了脑中神经酰胺的水平,而没有明显的鞘磷脂水解。这些数据符合我们在培养的少突胶质细胞中的发现,并表明在大脑缺血性脑损伤中发生了新的神经酰胺合成的早期激活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TATYANA GUDZ其他文献
TATYANA GUDZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TATYANA GUDZ', 18)}}的其他基金
SPHINGOLIPIDS IN INTEGRIN-MEDIATED OLIGODENDROCYTE SURVIVAL SIGNALING IN HYPOXI
缺氧时整合素介导的少突胶质细胞生存信号转导中的鞘脂
- 批准号:
7610449 - 财政年份:2007
- 资助金额:
$ 12.83万 - 项目类别:
SPHINGOLIPIDS IN INTEGRIN-MEDIATED OLIGODENDROCYTE SURVIVAL SIGNALING IN HYPOXIA
缺氧条件下整合素介导的少突胶质细胞生存信号传导中的鞘脂
- 批准号:
7171084 - 财政年份:2005
- 资助金额:
$ 12.83万 - 项目类别:
相似国自然基金
肠道病毒下调去整合素金属蛋白酶15促进病毒复制膜形成的机制研究
- 批准号:82302502
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
受M2a型巨噬细胞激活Integrin/FAK/SP1轴的RSPO3高表达成纤维细胞在肩关节僵硬中的作用与机制研究
- 批准号:82372491
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
益气除痰方干预COX-2-PGE2/β2 Integrin信号抑制肿瘤相关中性粒细胞促癌极化和黏附的抗肺癌转移机制
- 批准号:82374534
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
构建生物3D打印类器官芯片模型研究弹性蛋白-整合素在胃癌免疫微环境中的作用
- 批准号:32371472
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
海洋来源二倍半萜MHO7靶向整合素β8/TGF-β轴调控EMT抑制三阴性乳腺癌转移的作用机制研究
- 批准号:82304550
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
The impact of alcohol-induced ATF6-mediated ER stress and Golgi disorganization on pro-metastatic glycosylation of integrins in prostate cancer
酒精诱导的 ATF6 介导的 ER 应激和高尔基体解体对前列腺癌整合素促转移糖基化的影响
- 批准号:
10826211 - 财政年份:2023
- 资助金额:
$ 12.83万 - 项目类别:
Investigating the role and therapeutic potential of the alpha5beta1 integrin in risk factors for COVID-19-associated cognitive impairment
研究 α5β1 整合素在 COVID-19 相关认知障碍危险因素中的作用和治疗潜力
- 批准号:
10658178 - 财政年份:2023
- 资助金额:
$ 12.83万 - 项目类别:
Regulation of Flt 1 Splicing by Fibronectin and Integrin Signaling During Aging
衰老过程中纤连蛋白和整合素信号传导对 Flt 1 剪接的调节
- 批准号:
10777172 - 财政年份:2023
- 资助金额:
$ 12.83万 - 项目类别:
Identifying Mechanisms Involved in Hydroxyurea-Mediated Reduction in Vaso-occlusive Adhesive Events in Sickle Cell Disease
确定羟基脲介导的镰状细胞病血管闭塞性粘附事件减少机制
- 批准号:
10724590 - 财政年份:2023
- 资助金额:
$ 12.83万 - 项目类别:
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
7HP349,一种口服整合素激活剂,可增强暴露前流感疫苗接种的有效性
- 批准号:
10693536 - 财政年份:2023
- 资助金额:
$ 12.83万 - 项目类别: